Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Kodiak Sciences (KOD) Shares Outstanding (Diluted Average) (2020 - 2026)

Kodiak Sciences filings provide 7 years of Shares Outstanding (Diluted Average) readings, the most recent being $61.9 million for Q1 2026.

  • Quarterly Shares Outstanding (Diluted Average) rose 17.28% to $61.9 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $61.9 million through Mar 2026, up 17.28% year-over-year, with the annual reading at $53.2 million for FY2025, 1.19% up from the prior year.
  • Shares Outstanding (Diluted Average) hit $61.9 million in Q1 2026 for Kodiak Sciences, up from $53.2 million in the prior quarter.
  • Across five years, Shares Outstanding (Diluted Average) topped out at $61.9 million in Q1 2026 and bottomed at $52.2 million in Q1 2022.
  • Average Shares Outstanding (Diluted Average) over 5 years is $53.1 million, with a median of $52.5 million recorded in 2024.
  • The largest annual shift saw Shares Outstanding (Diluted Average) rose 0.2% in 2024 before it grew 17.28% in 2026.
  • Kodiak Sciences' Shares Outstanding (Diluted Average) stood at $52.2 million in 2022, then increased by 0.32% to $52.4 million in 2023, then increased by 0.32% to $52.6 million in 2024, then rose by 1.19% to $53.2 million in 2025, then increased by 16.26% to $61.9 million in 2026.
  • Per Business Quant, the three most recent readings for KOD's Shares Outstanding (Diluted Average) are $61.9 million (Q1 2026), $53.2 million (Q4 2025), and $52.8 million (Q3 2025).